BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28763236)

  • 21. Generation of a fusion protein of the extracellular domain of BR3 with the Fc fragment of human IgG1 (sBR3-Fc) in Pichia pastoris as an antagonist for BLyS.
    Cao P; Zhang S; Fang Z; Huang H; Bai P; Zhang Q; Luo C
    Appl Microbiol Biotechnol; 2008 Feb; 78(2):275-82. PubMed ID: 18189138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical characterization of a new recombinant TNF receptor-hyFc fusion protein expressed in CHO cells.
    Lee JH; Yeo J; Park HS; Sung G; Lee SH; Yang SH; Sung YC; Kang JH; Park CS
    Protein Expr Purif; 2013 Jan; 87(1):17-26. PubMed ID: 23009882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and characterization of a DNase I-Fc fusion enzyme.
    Dwyer MA; Huang AJ; Pan CQ; Lazarus RA
    J Biol Chem; 1999 Apr; 274(14):9738-43. PubMed ID: 10092662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fc Engineering of Human IgG1 for Altered Binding to the Neonatal Fc Receptor Affects Fc Effector Functions.
    Grevys A; Bern M; Foss S; Bratlie DB; Moen A; Gunnarsen KS; Aase A; Michaelsen TE; Sandlie I; Andersen JT
    J Immunol; 2015 Jun; 194(11):5497-508. PubMed ID: 25904551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and characterization of human growth hormone-Fc fusion proteins for transcytosis induction.
    Lee CH; Woo JH; Cho KK; Kang SH; Kang SK; Choi YJ
    Biotechnol Appl Biochem; 2007 Apr; 46(Pt 4):211-7. PubMed ID: 17067288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stabilisation of the Fc fragment of human IgG1 by engineered intradomain disulfide bonds.
    Wozniak-Knopp G; Stadlmann J; Rüker F
    PLoS One; 2012; 7(1):e30083. PubMed ID: 22272277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.
    Suzuki T; Ishii-Watabe A; Tada M; Kobayashi T; Kanayasu-Toyoda T; Kawanishi T; Yamaguchi T
    J Immunol; 2010 Feb; 184(4):1968-76. PubMed ID: 20083659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon gamma receptor extracellular domain expressed as IgG fusion protein in Chinese hamster ovary cells. Purification, biochemical characterization, and stoichiometry of binding.
    Fountoulakis M; Mesa C; Schmid G; Gentz R; Manneberg M; Zulauf M; Dembic Z; Garotta G
    J Biol Chem; 1995 Feb; 270(8):3958-64. PubMed ID: 7876143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineered soluble monomeric IgG1 CH3 domain: generation, mechanisms of function, and implications for design of biological therapeutics.
    Ying T; Chen W; Feng Y; Wang Y; Gong R; Dimitrov DS
    J Biol Chem; 2013 Aug; 288(35):25154-25164. PubMed ID: 23867459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn.
    Popov S; Hubbard JG; Kim J; Ober B; Ghetie V; Ward ES
    Mol Immunol; 1996 Apr; 33(6):521-30. PubMed ID: 8700168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression of human IL-35-IgG4 (Fc) fusion protein in CHO/DG44 cells].
    Tang J; Gao W; Zhang Q; Zhang D; Chen Y; He B; Liu Q
    Sheng Wu Gong Cheng Xue Bao; 2009 Jan; 25(1):109-15. PubMed ID: 19441235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies.
    Davis JH; Aperlo C; Li Y; Kurosawa E; Lan Y; Lo KM; Huston JS
    Protein Eng Des Sel; 2010 Apr; 23(4):195-202. PubMed ID: 20299542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering the hinge region of human IgG1 Fc-fused bispecific antibodies to improve fragmentation resistance.
    Suzuki S; Annaka H; Konno S; Kumagai I; Asano R
    Sci Rep; 2018 Nov; 8(1):17253. PubMed ID: 30467410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A small domain (6.5 kDa) of bacterial protein G inhibits C3 covalent binding to the Fc region of IgG immune complexes.
    Muñoz E; Vidarte L; Pastor C; Casado M; Vivanco F
    Eur J Immunol; 1998 Aug; 28(8):2591-7. PubMed ID: 9710236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake of recombinant myeloperoxidase, free or fused to Fc gamma, by macrophages enhances killing activity toward micro-organisms.
    Tournay C; Courtoy PJ; Marodi L; Totté P; Werenne J; Jacquet A; Garcia-Quintana L; Bollen A; Moguilevsky N
    DNA Cell Biol; 1996 Aug; 15(8):617-24. PubMed ID: 8769563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineering the fragment crystallizable (Fc) region of human IgG1 multimers and monomers to fine-tune interactions with sialic acid-dependent receptors.
    Blundell PA; Le NPL; Allen J; Watanabe Y; Pleass RJ
    J Biol Chem; 2017 Aug; 292(31):12994-13007. PubMed ID: 28620050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.
    Wright A; Morrison SL
    J Exp Med; 1994 Sep; 180(3):1087-96. PubMed ID: 8064227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-level expression of human CH2 domain from the Fc region in Pichia pastoris and preparation of anti-CH2 antibodies.
    Oyama K; Ohkuri T; Inoue M; Caaveiro JMM; Ueda T
    J Biochem; 2021 Oct; 170(2):289-297. PubMed ID: 33772592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of rhEPO-L-Fc fusion protein and analysis of its bioactivity and pharmacokinetics].
    Zhu Q; Huang Z; Huang Y; Qin Y
    Sheng Wu Gong Cheng Xue Bao; 2008 Nov; 24(11):1874-9. PubMed ID: 19256332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake.
    Rotman M; Welling MM; van den Boogaard ML; Moursel LG; van der Graaf LM; van Buchem MA; van der Maarel SM; van der Weerd L
    Nucl Med Biol; 2015 Aug; 42(8):695-702. PubMed ID: 25960433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.